Cash-flow figures use the latest fiscal year: this filer tags quarterly cash flows year-to-date only and the missing discrete quarters could not be derived (irregular fiscal quarters or a tagging change), so no four consecutive quarters exist to sum.
No four consecutive quarters could be summed for EPS (Diluted); these figures use the latest fiscal year, not a trailing twelve months.
full derived coverage requires a plan
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
— Months · distinct values (the real sample size).
Metric
Today
Own median
Own range
%ile
z
Sector med.
mo · distinct
40.97×
25.67×
69th
+0.41σ
24.86×
79 · 79
153.6%
110.2%
62nd
+0.52σ
−36.9%
103 · 9
16.7%
18.1%
41st
+0.36σ
−15.4%
127 · 11
22.7%
19.9%
54th
+0.40σ
−21.3%
138 · 12
36.6%
22.5%
75th
+0.54σ
5.1%
141 · 141
21.1%
26.5%
no band (43 mo · 4 distinct)
—
—
8.4%
43 · 4
28.4%
31.8%
38th
−0.07σ
9.0%
103 · 9
Market Cap
$11.90B
not reconstructed — market cap was removed from the historical pass (never a ranking factor, and a reconstructed share count carries look-ahead risk). The single stored value is the forward-captured snapshot, not a series.
Own median 25.67× × $2.56 = $65.71vs the $107.62 close · earnings held constant
Own multiple
P/E
Implied price
vs close
10th percentile
16.69×
$42.74
−60.3%
25th percentile
19.50×
$49.91
−53.6%
median
25.67×
$65.71
−38.9%
75th percentile
36.41×
$93.21
−13.4%
90th percentile
44.29×
$113.38
+5.4%
today
42.04×
$107.62
—
Reference computation · 79 monthly P/E observations in Full · EPS basis FY2025 EPS (Diluted) $2.56 · close $107.62 (2026-08-19)ⓘ
Not a forecast: each row re-prices today's filed earnings at a multiple this company itself once traded at. It abstains rather than guess on a loss year or a broken per-share basis.
Every month uses only what was filed by then, split-adjusted. Delisted names are absent and a trough year can throw one huge reading, so read the median, not the edges.
Percentile through time (point-in-time cohort)
Loading the monthly cohort placement…
▸Comp setname your own peers — pick a pool or add tickers
Covered pool$977.78B +7.6%/yr 2020→2025Concentration484 of 10,000fragmented · top 3 hold 22.9% · −24 pts since 2020HALO0.1% · rank 45 of 348 · +0.1pp over 5y· CV 0.59 · σ 0.0pp
Who holds the poolCY2025 · bars scaled to the largest member
Growth, restated as sharewhere each pace has to END UP, by 2030
Its own realised pace0.1% → 0.3%
The pace the price requires— The growth today's price requires (our reverse-DCF) is a Pro metric — the realized-pace runway above is free.
HALO share over timelast 6 of 10 published years
Calendar year
2020
2021
2022
2023
2024
2025
Share of covered pool
0.0%
0.1%
0.1%
0.1%
0.1%
0.1%
coverage: 321 of the 385 members that…
Share of covered industry revenue · n=348 in Pharmaceuticals & Biotechnology · CY2025 pool · built 2026-08-20 not market shareⓘ
Covered filers only, not market share — private and uncovered companies are missing, so every share here reads high. Years are FX-converted and published only once most of the pool has filed.
